
Arthrosamid Treatment for Medial-Compartment Knee Osteoarthritis
Medial-compartment knee osteoarthritis (OA) affects the inner knee, causing pain and stiffness due to cartilage wear from weight-bearing stress. Arthrosamid, a hydrogel injectable treatment, offers a novel approach by restoring cushioning within the knee joint, effectively reducing pain and improving mobility. Research shows Arthrosamid to be safe and efficacious, with ongoing studies identifying patient factors for optimal benefit. The London Cartilage Clinic, led by cartilage expert Professor Paul Lee, provides expert assessment and personalised care for knee OA patients. This innovative treatment can enhance quality of life, potentially delaying surgery, making it a promising option for those with medial knee OA symptoms. Consultation with healthcare professionals is essential for tailored management.









